1.
|
Details of PDMR/person closely associated with them
('PCA')
|
||
a)
|
Name
|
Mrs V A Whyte
|
|
b)
|
Position/status
|
Company Secretary
|
|
c)
|
Initial notification/
amendment
|
Initial notification
|
|
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
||
a)
|
Name
|
GlaxoSmithKline plc
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
||
a)
|
Description
of
the
financial
instrument
|
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN:
GB0009252882
|
|
b)
|
Nature
of
the
transaction
|
Acquisition of Ordinary Shares following the re-investment of
dividends paid to shareholders on 11 January
2018.
|
|
c)
|
Price(s)
and volume(s)
|
Price(s)
|
Volume(s)
|
£13.3409
|
64
|
||
d)
|
Aggregated
information
Aggregated
volume
Price
|
n/a (single transaction)
|
|
e)
|
Date of
the
transaction
|
2018-01-11
|
|
f)
|
Place
of
the transaction
|
London Stock Exchange (XLON)
|
1.
|
Details of PDMR/person closely associated with them
('PCA')
|
||
a)
|
Name
|
Mr I W Whyte
|
|
b)
|
Position/status
|
PCA of Mrs V A Whyte (Company Secretary)
|
|
c)
|
Initial notification/
amendment
|
Initial notification
|
|
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
||
a)
|
Name
|
GlaxoSmithKline plc
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
||
a)
|
Description
of
the
financial
instrument
|
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN:
GB0009252882
|
|
b)
|
Nature
of
the
transaction
|
Acquisition of Ordinary Shares following the re-investment of
dividends paid to shareholders on 11 January
2018.
|
|
c)
|
Price(s)
and volume(s)
|
Price(s)
|
Volume(s)
|
£13.3409
|
471
|
||
d)
|
Aggregated
information
Aggregated
volume
Price
|
n/a (single transaction)
|
|
e)
|
Date of
the
transaction
|
2018-01-11
|
|
f)
|
Place
of
the transaction
|
London Stock Exchange (XLON)
|
1.
|
Details of PDMR/person closely associated with them
('PCA')
|
||
a)
|
Name
|
Mrs D Connor
|
|
b)
|
Position/status
|
PCA of Mr R G Connor (President, Global Manufacturing &
Supply)
|
|
c)
|
Initial notification/
amendment
|
Initial notification
|
|
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
||
a)
|
Name
|
GlaxoSmithKline plc
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
||
a)
|
Description
of
the
financial
instrument
|
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN:
GB0009252882
|
|
b)
|
Nature
of
the
transaction
|
Acquisition of Ordinary Shares following the re-investment of
dividends paid to shareholders on 11 January
2018.
|
|
c)
|
Price(s)
and volume(s)
|
Price(s)
|
Volume(s)
|
£13.3409
|
300
|
||
d)
|
Aggregated
information
Aggregated
volume
Price
|
n/a (single transaction)
|
|
e)
|
Date of
the
transaction
|
2018-01-11
|
|
f)
|
Place
of
the transaction
|
London Stock Exchange (XLON)
|
|
GlaxoSmithKline plc
|
|
(Registrant)
|
|
|
Date: January
15, 2018
|
|
|
|
|
By: VICTORIA
WHYTE
--------------------------
|
|
|
|
Victoria Whyte
|
|
Authorised
Signatory for and on
|
|
behalf
of GlaxoSmithKline plc
|